SCIREX Appoints Samer E. Kaba, MD, as VP Clinical Research and Medical Management

Share Article

SCIREX Corporation today announced the appointment of Dr. Samer E. Kaba to the position of Vice President Clinical Research and Medical Management. Dr. Kaba will direct the operations of the Medical Management and Safety group, monitor the medical and safety aspects of projects managed by the company and provide medical and safety consulting services to Sponsors, clinical sites and project teams.

SCIREX Corporation today announced the appointment of Dr. Samer E. Kaba to the position of Vice President Clinical Research and Medical Management. Dr. Kaba will direct the operations of the Medical Management and Safety group, monitor the medical and safety aspects of projects managed by the company and provide medical and safety consulting services to Sponsors, clinical sites and project teams.

Dr. Kaba joins SCIREX from PRA International, where most recently he was Senior Director, CNS, Global Product Development Services, responsible for formulating clinical development strategies and providing consultative and life cycle management advisory services for new therapies.

Dr. Kaba is a graduate of the Damascus University School of Medicine and did residency training in internal medicine and neurology at the State University of New York (SUNY), Buffalo. He completed fellowships in neuro-immunology/multiple sclerosis at SUNY, and in neuro-oncology at the University Of Texas M. D. Anderson Cancer Center in Houston, where he also served as a faculty member. Dr. Kaba currently holds an adjunct faculty position at the Department of Neurology at Emory University in Atlanta. He served as the Director of Research at the Shepherd MS Center in Atlanta and as Assistant Professor at the University of Arkansas in Little Rock, where he also managed a private neurology practice. Dr. Kaba is certified by the American Board of Psychiatry and Neurology and has multiple scientific publications on topics relating to CNS diseases and disorders. He holds professional memberships in the American Academy of Neurology, the Society for Neuro-Oncology, the American Society of Clinical Oncology, and the American Academy of Pharmaceutical Physicians.

“This is a significant appointment for SCIREX,” said John Whalen, M.D., General Manager, Clinical Development Services. “Since excellence in clinical trial design and patient safety are at the heart of the services we provide our clients, Dr. Kaba’s academic achievements, his experience as a clinician and his substantial industry experience make him superbly qualified to lead these critical areas of our operations.”

About SCIREX

SCIREX Corporation is a leader in the delivery of Phase I-IV drug development services to the global pharmaceutical and biotechnology industries. SCIREX’s clinical trial management capabilities include drug development planning, protocol design, submission services, regulatory affairs consulting, investigator and patient recruitment, data management, statistics, medical writing and offers an array of technology solutions including IVRS, EDC and SIMS(TM) (Study Information Management System). SCIREX’s experience portfolio includes more than 1,000 clinical trials involving well over 100,000 patients, evaluating new treatments for pain and inflammation, neurological and psychiatric disorders, infectious diseases and gastrointestinal and cardiovascular indications. SCIREX is a wholly-owned subsidiary of Omnicom Group, Inc.

For more information contact Blythe Vito, SCIREX Corporate Marketing at (215) 907-1330 x1054, or visit http://www.scirex.com.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Blythe Vito
Visit website